Acknowledging obesity and hypertension in the pediatric population
A recap of the American College of Cardiology meeting and discussion of obesity and hypertension in the pediatric population.
Nirsevimab reduced RSV hospitalizations in infants by 82%, new data show
The new data, published in The Lancet, showed that nirsevimab substantially reduced RSV hospitalizations.
Parent perspectives: How are parents providing healthy diets for their children?
A recent nationally representative survey revealed what types of meals parents believe are healthy for their children, and how much food is the healthy amount.
Determining accuracy of ICD-10 influenza diagnosis codes in ED, inpatient settings
ICD-10 accuracy varied by age of the patient, influenza season definition, time between onset and testing, and clinical setting.
Tricuspid regurgitation velocity linked to cerebrovascular, kidney disease in SCD
A higher TRV was significantly associated with cerebrovascular disease and persistent albuminuria in children with SCD across two large cohorts.
BLA resubmitted for lebrikizumab to treat AD patients 12 years and up
The resubmission was announced in a first quarter, 2024 earnings news release from Lilly, which expects "regulatory action in the second half of 2024."
Stigmatization of chronic skin disorders plays role in children's quality of life
Data from a recent study revealed that stigma associated with chronic skin diseases made an impact on the quality of life of affected children and adolescents.
A deep dive into Qbtech's diagnostic ADHD test
A discussion based on an FDA-cleared objective ADHD diagnostic test developed by Qbtech.
FDA approves mavorixafor as first drug for WHIM syndrome
The rare genetic disease causes the body's immune system to not function properly.
FDA accepts sNDA for tapinarof cream, 1% to treat AD in children 2 years and up
A decision from the federal agency is expected in the fourth quarter of 2024.
FDA approves diazepam for seizure clusters in patients 2 to 5 years
With the approval comes the immediate availability of 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg doses for patients between 2 to 5 years of age.
Week in review: FDA approvals, CRL for DEB, and more
Get caught up with our journal! Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.
COVID-19 vaccines safe for children, despite observed myocarditis, seizure risks
New cohort analyses observe a statistically raised risk of myocarditis, pericarditis and seizures among certain age groups, though the data do not go against FDA recommendations.
Marijuana legalization not associated with encouraged use among youth
Though concern exists about the associations of marijuana legalization and youth use, no links were found in a recent study.
Study: Neonatal outcomes not associated with hyperoxygenation use
Research in AJOG: Maternal hyperoxygenation doesn't boost neonatal Apgar scores in pathologic fetal heart rate tracing, showing no FiO2 benefit.
Antenatal corticosteroids not linked to child neurodevelopment, study finds
Study in JAMA: Antenatal corticosteroids don't impact neurodevelopment in late preterm children aged 6 years and up.
Incorporating objective testing to add value to an ADHD diagnosis
Perry Roy, MD, explains how an FDA-cleared objective test can assist in an ADHD diagnosis.
Infants born into a digital world: Are there developmental inequities based on exposure?
Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, highlights the April 2024 issue of Contemporary Pediatrics.
FDA approves tovorafenib for most common form of childhood brain tumor
This decision from the federal agency marks the first FDA approval of a systemic therapy to treat patients with pediatric LGG with BRAF rearrangements, including fusions.
First radioactive drug approved for patients 12 years and up with SSTR-positive GEP-NETs
The FDA has approved lutetium Lu 177 dotatate for pediatric patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors.
Ustekinumab biosimilar approved to treat moderate to severe plaque psoriasis
The biosimilar to ustekinumab is approved for patients 6 years and up, and is expected to be marketed on or after February 21, 2025.
CRL issued for pz-cel as potential recessive dystrophic epidermolysis bullosa treatment
Abeona's pz-cel is up for indicated use to treat patients with recessive dystrophic epidermolysis bullosa.
Pandemic's impact on early childhood development may have been minimal
An assessment into development scores before, during and after the COVID-19 pandemic show children aged 0 - 5 years old may only had been minimally impacted in communication and problem-solving skills.
Intravenous iron increases hemoglobin levels in children with anemia, IBD
Treatment with intravenous iron therapy proves more efficacious than oral or no iron therapy in improving hemoglobin in pediatric patients admitted with IBD and IDA.
Week in review: BLA accepted for meningococcal vaccine, single-tablet HIV regimen data
Children with sleep disorders have double the odds of increased health care usage
A new study explored increased health care utilization of children among several specific sleep disorders, race, and age.
RSV hospitalizations quadrupled among young children after COVID-19
Cohort analysis shows the rate of RSV hospitalizations among children up to 5 years old skyrocketed in 2021—and then nearly doubled again in 2022—compared to pre-pandemic rates.
No association between COVID-19 and development of asthma among children
This analysis looked at the potential connection between SARS-CoV-2 test positivity and new asthma diagnoses.
Managing and treating eating disorders
A discussion of outpatient management and treatment of eating disorders in youth patients, plus the importance of a multidisciplinary team throughout the process.
The benefits of concurrent fetal and maternal heart rate monitoring
A recent study revealed that employing maternal heart rate monitoring alongside fetal heart rate monitoring during labor significantly decreases the incidence of neonatal encephalopathy and severe neonatal acidemia.